Filing Details
- Accession Number:
- 0000014272-16-000409
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-05 17:31:25
- Reporting Period:
- 2016-05-03
- Filing Date:
- 2016-05-05
- Accepted Time:
- 2016-05-05 16:31:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1533201 | Giovanni Caforio | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2016-05-03 | 21,615 | $27.01 | 132,263 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2016-05-03 | 15,145 | $71.32 | 117,118 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2016-05-03 | 28,840 | $23.12 | 145,958 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2016-05-03 | 19,449 | $71.30 | 126,509 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2016-05-03 | 21,615 | $0.00 | 21,615 | $27.01 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2016-05-03 | 28,840 | $0.00 | 28,840 | $23.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-05 | No | 4 | M | Direct | |
| 0 | 2018-03-03 | No | 4 | M | Direct |
Footnotes
- These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $71.31 to $71.34, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- These shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions.
- All of the shares are currently exercisable.
Billionaire Hedge Funds
